CNSP
CNS Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
5.06 / 10
Netural
Analyst sentiment is overwhelmingly bullish (Strong Buy 100%) but based on only one research source, limiting reliability. Money flow analysis shows a good score (7.38/10) with positive medium-scale inflows, yet overall and block trends are negative, hinting at short-term profit-taking. The mismatch between strong buy ratings and negative price trend underscores the need for confirmation before taking decisive positions.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-12
InstitutionMaxim Group
Times predicted2
Historical Win Rate50.0%
What is the market sentiment for CNSP?
- CNSP holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.06/10 (Netural).
